Physician profile
Donald K Middleton
NPI 1235190364
$5,248.84
in general payments reported to CMS, 2019-2025
17 companies · $2,986 in 2025
The $2,986 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $990 · 2020: $192 · 2021: $80.67 · 2022: $311 · 2023: $169 · 2024: $519 · 2025: $2,986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,903 · Travel and Lodging: $1,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,903.31 |
| Travel and Lodging | $1,771.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,385.13 | 2019-2025 | Real Intelligence, Journey, Journey II |
| Stryker Corporation | $1,019.57 | 2019-2025 | Mako |
| Medacta USA, INC. | $354.61 | 2020-2024 | |
| Depuy Synthes Sales INC. | $84.35 | 2022-2025 | Cor, Monovisc, Orthovisc |
| Ferring Pharmaceuticals INC. | $56.88 | 2019-2023 | Euflexxa |
| Heraeus Medical, LLC. | $48.84 | 2021-2023 | Palacos |
| Ethicon US, LLC | $48.14 | 2022 | |
| Convatec INC. | $44.96 | 2021-2022 | |
| Bioventus LLC | $31.55 | 2019 | |
| Zimmer Biomet Holdings, INC. | $29.12 | 2020-2025 | Tapestry, Avitus Bone Harvester |
| Vertex Pharmaceuticals Incorporated | $27.85 | 2025 | |
| Pacira Therapeutics, INC. | $27.49 | 2019 | |
| Cerapedics INC. | $26.55 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Orthofix Medical, INC. | $23.68 | 2022 | |
| Baxter Healthcare | $14.64 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Enduromed, LLC | $13.32 | 2023 | |
| Dynasplint Systems INC. | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Middleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.